The pharmacology of lysergic acid diethylamide: a review.
about
Personality, psychopathology, life attitudes and neuropsychological performance among ritual users of Ayahuasca: a longitudinal studyVisual trails: do the doors of perception open periodically?Lysergic acid diethylamide (LSD) for alcoholism: meta-analysis of randomized controlled trialsLysergic acid diethylamide: a drug of 'use'?Antidepressive, anxiolytic, and antiaddictive effects of ayahuasca, psilocybin and lysergic acid diethylamide (LSD): a systematic review of clinical trials published in the last 25 yearsPsychedelics and Immunomodulation: Novel Approaches and Therapeutic OpportunitiesToxicities associated with NBOMe ingestion-a novel class of potent hallucinogens: a review of the literatured-Lysergic Acid Diethylamide (LSD) as a Model of Psychosis: Mechanism of Action and Pharmacology.Mefloquine and psychotomimetics share neurotransmitter receptor and transporter interactions in vitroPsychedelicsLSD enhances the emotional response to music.LSD-induced entropic brain activity predicts subsequent personality change.Modern Clinical Research on LSD.Alterations of consciousness and mystical-type experiences after acute LSD in humans.Acute effects of LSD on amygdala activity during processing of fearful stimuli in healthy subjects.A Single Dose of LSD Does Not Alter Gene Expression of the Serotonin 2A Receptor Gene (HTR2A) or Early Growth Response Genes (EGR1-3) in Healthy Subjects.Safety and efficacy of lysergic acid diethylamide-assisted psychotherapy for anxiety associated with life-threatening diseases.The non-hallucinogen 2-bromo-lysergic acid diethylamide as preventative treatment for cluster headache: an open, non-randomized case series.Absorption, distribution, metabolism and excretion pharmacogenomics of drugs of abuse.The NBOMe hallucinogenic drug series: Patterns of use, characteristics of users and self-reported effects in a large international sample."My friend said it was good LSD": a suicide attempt following analytically confirmed 25I-NBOMe ingestion.Pharmacokinetics and Concentration-Effect Relationship of Oral LSD in Humans.Return of the lysergamides. Part I: Analytical and behavioural characterization of 1-propionyl-d-lysergic acid diethylamide (1P-LSD)Clinical applications of hallucinogens: A review.Drug Abuse and Psychosis: New Insights into Drug-induced PsychosisErgot alkaloids produced by endophytic fungi of the genus Epichloë.Evolutionary constraints on visual cortex architecture from the dynamics of hallucinations.Serotonergic and dopaminergic distinctions in the behavioral pharmacology of (±)-1-(2,5-dimethoxy-4-iodophenyl)-2-aminopropane (DOI) and lysergic acid diethylamide (LSD).Phospholipase C mediates (±)-1-(2,5-dimethoxy-4-iodophenyl)-2-aminopropane (DOI)-, but not lysergic acid diethylamide (LSD)-elicited head bobs in rabbit medial prefrontal cortexLSD Acutely Impairs Fear Recognition and Enhances Emotional Empathy and SocialitySensory dynamics of visual hallucinations in the normal population.Forensic aspects of drug-induced violence.Emerging treatment for chronic migraine and refractory chronic migraine.Alternative drugs of abuse.Licit and illicit drug use in cluster headache.Peak experiences and the afterglow phenomenon: when and how do therapeutic effects of hallucinogens depend on psychedelic experiences?Dreamlike effects of LSD on waking imagery in humans depend on serotonin 2A receptor activation.Development and validation of an LC-MS/MS method to quantify lysergic acid diethylamide (LSD), iso-LSD, 2-oxo-3-hydroxy-LSD, and nor-LSD and identify novel metabolites in plasma samples in a controlled clinical trial.Pharmacokinetics and Pharmacodynamics of Lysergic Acid Diethylamide in Healthy Subjects.Ergoline-derived inverse agonists of the human h3 receptor for the treatment of narcolepsy.
P2860
Q21134103-2C6BFDB4-8DC2-474E-B359-FCD53A0F51A7Q21145773-1C70D7B6-38E7-48C5-9322-B8A921604AD4Q22241828-B564ED1D-C06F-4303-8C1F-6AEAA0AF298DQ26746133-A050FA69-EF01-4F12-9CB4-81A71402C5EEQ26746137-16A447A4-3213-47D3-9B86-987F2B21434EQ26799997-2012A440-5AF2-47CD-92F7-3EE6CFE0895CQ26865329-55D03B17-A30B-4655-9F8D-6D33E1E2F540Q28067851-D78D2E58-F187-462D-89FF-3F3530992435Q28307141-C8653B7A-8708-41C6-8DC9-976ABC971652Q30359998-2B7D503A-DDBF-4645-8059-C5E6BCCC4C2BQ30377709-274D384F-28E2-45B6-97F3-98556D9DB863Q30387757-EDB57132-F4E1-42CA-B92E-11280B2B4BF4Q30401421-B7057487-A719-4403-95DF-ACF2E551F791Q30847957-86412AA4-03B3-468E-89B1-790EF7559CCBQ33635662-052AC713-60AC-455A-BEE2-A73F6B653DF9Q33843524-73796680-1606-430B-99C5-2C424D02AF21Q33863459-A6793E80-3E81-42E5-905A-D57DB8701409Q34131481-0D2F10EE-267B-4F87-9B2E-8AB6383535FCQ34165511-53138BF8-FBAD-499C-9500-13B7448A8D95Q34406732-287BB3F0-62CE-45F6-8D28-6C586F9D72EDQ34453002-632D0301-53CE-4C5B-8A16-B73E78BA8070Q34482174-2B63A1E1-7F04-43EA-8CB3-05B07960599EQ34497649-AEB83FA7-4EA9-41B5-95C1-A9725B67670BQ34535259-50ECD3A2-5582-4039-A0F6-F224942AA95DQ34680922-A11C37EC-5A6E-42F7-A284-17C9E1EC86D4Q35232716-2D2EBAE4-D53A-4CDC-87EC-44D7752E239CQ35673851-2A740C9A-7719-4002-B2FD-6C0B6AF56BBEQ35737157-E9F33873-B770-4CBC-85FC-A21486BA5F44Q36574422-702E8650-59EA-4688-880C-02FC10812DE3Q37262799-B7CF80AA-6F5E-4AC3-BE10-6F1C8366D6E1Q37329064-334FABC8-006F-4AE7-ABC3-6629D0573CC8Q37973043-33E7CD34-CEAA-4801-8067-434E0A711F5EQ38031982-39C0A3BF-3B1D-498C-BC24-8BDF025DD307Q38103475-1E77FEE8-EAEB-4C5C-AFD9-FC83BDC55269Q38203237-62C61B9C-F212-49A6-88E6-3ABC5747FCA9Q38351502-ABD5D049-53B4-469E-964A-D6613E5942A6Q38733778-DB25D703-5961-42BF-B0F1-88459164A958Q38761743-A0B886D8-35E4-4280-A791-F524073BD931Q38961114-12444BDB-968A-4786-93DE-AFE67DD71ADDQ38992826-4BFB65E3-5E4C-4A7D-9E65-17B1A8FB6AEA
P2860
The pharmacology of lysergic acid diethylamide: a review.
description
2008 nî lūn-bûn
@nan
2008 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2008 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
name
The Pharmacology of Lysergic Acid Diethylamide: A Review
@ast
The Pharmacology of Lysergic Acid Diethylamide: A Review
@nl
The pharmacology of lysergic acid diethylamide: a review.
@en
type
label
The Pharmacology of Lysergic Acid Diethylamide: A Review
@ast
The Pharmacology of Lysergic Acid Diethylamide: A Review
@nl
The pharmacology of lysergic acid diethylamide: a review.
@en
altLabel
The pharmacology of lysergic acid diethylamide: a review
@en
prefLabel
The Pharmacology of Lysergic Acid Diethylamide: A Review
@ast
The Pharmacology of Lysergic Acid Diethylamide: A Review
@nl
The pharmacology of lysergic acid diethylamide: a review.
@en
P2093
P2860
P3181
P1476
The pharmacology of lysergic acid diethylamide: a review.
@en
P2093
Annelie Hintzen
Dirk O Stichtenoth
Hinderk M Emrich
John H Halpern
Torsten Passie
P2860
P304
P3181
P356
10.1111/J.1755-5949.2008.00059.X
P407
P577
2008-01-01T00:00:00Z